Ikarian Capital »

Rezolute shares owned by Ikarian Capital

Quarter-by-quarter ownership of Rezolute (RZLT) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Rezolute

Tip: Access up to 7 years of quarterly data

All positions including Rezolute held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rezolute by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.9M 904k 4.30

More positions owned by Ikarian Capital

Sarepta Therapeutics Call Option (SRPT)
Amgen Call Option (AMGN)
Bridgebio Pharma Call Option (BBIO)
Immunovant Call Option (IMVT)
Neurocrine Biosciences Call Option (NBIX)
Pyxis Oncology Common Stock Call Option (PYXS)
Insmed Com Par $.01 Call Option (INSM)
Abeona Therapeutics Com New Call Option (ABEO)
Alnylam Pharmaceuticals Put Option (ALNY)
Aerovate Therapeutics Call Option (AVTE)
Rapt Therapeutics Call Option (RAPT)
Praxis Precision Medicines I Com New Call Option (PRAX)
Crinetics Pharmaceuticals In (CRNX)
Tarsus Pharmaceuticals (TARS)
Soleno Therapeutics (SLNO)

View all positions for Ikarian Capital

Top funds holding Rezolute

Federated Investors
Nantahala Capital Management
Affinity Asset Advisors
Blackstone Group
Sphera Funds Management
Altium Capital Management
Vanguard Group
Ghost Tree Capital
Alyeska Investment Group
Marshall Wace
Ikarian Capital
Morgan Stanley
BlackRock
Geode Capital Management
Citadel Advisors

View all funds holding Rezolute